Hyfipime TZ 250mg/31.25mg Injection
Marketer
Hiya Lifesciences Pvt Ltd
Salt Composition
Cefepime (250mg) + Tazobactum (31.25mg)
Overview Hyfipime TZ 250mg/31.25mg Injection
The antibiotic combination Hyfipime TZ Injection (250mg/31.25mg) combats bacterial infections by inhibiting microbial growth. Administered only by a healthcare provider, this medication requires adherence to the prescribed schedule; complete the full course regardless of symptom improvement. Commonly reported side effects include gastrointestinal upset (nausea, vomiting, diarrhea), skin reactions (rashes), and localized injection site reactions (redness, swelling, pain) which typically resolve spontaneously. Severe or persistent side effects necessitate immediate medical attention. Allergic reactions (skin rashes, itching, swelling, breathing difficulties) demand immediate emergency care. Inform your physician of all current medications, including those for pre-existing conditions, before commencing treatment. Pregnant or lactating individuals should consult their doctor prior to use. Alcohol consumption should be avoided due to the potential for increased drowsiness. While generally not impairing driving ability, refrain from operating vehicles if experiencing drowsiness or dizziness.
Uses of Hyfipime TZ 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Hyfipime TZ 250mg/31.25mg Injection:
This medication will be administered by your physician or their qualified associate; self-medication is strictly prohibited.
Common Side effects of Hyfipime TZ 250mg/31.25mg Injection:
- Diarrhea
- Increased white blood cell count (eosinophils)
- Injection site phlebitis
- Skin rash
- Increased liver enzymes
- Positive Coombs test
How to use Hyfipime TZ 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Hyfipime TZ 250mg/31.25mg Injection works:
Hyfipime TZ 250mg/31.25mg injection unites cefepime, a bacterial growth inhibitor, with tazobactam, a beta-lactamase inhibitor. Cefepime's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Tazobactam counteracts bacterial enzymes that would otherwise neutralize cefepime, thereby broadening cefepime's effectiveness and overcoming bacterial resistance.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Hyfipime TZ 250mg/31.25mg Injection alongside alcohol. Physician consultation is recommended.
PregnancySAFE IF PRESCRIBED
Administration of Hyfipime TZ 250mg/31.25mg Injection is typically deemed safe for pregnant individuals. Preclinical trials using animal models revealed minimal or no harmful effects on fetal development; nevertheless, clinical data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Hyfipime TZ 250mg/31.25mg is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.
DrivingUNSAFE
Following administration of Hyfipime TZ 250mg/31.25mg Injection, temporary blurred vision may occur. Refrain from driving until your vision returns to normal.
KidneyCAUTION
The injectable medication, Hyfipime TZ 250mg/31.25mg, requires careful administration to individuals with impaired kidney function. Dosage modification for Hyfipime TZ 250mg/31.25mg Injection may be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Hyfipime TZ 250mg/31.25mg Injection in individuals with hepatic impairment is likely safe. Preliminary findings indicate dose modification may be unnecessary; however, medical advice is recommended.
What if you forget to take Hyfipime TZ 250mg/31.25mg Injection :
Should you forget a scheduled dose of Hyfipime TZ 250mg/31.25mg Injection, seek medical advice.
Facts to Know About Hyfipime TZ 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently